Announce Date | 05/07/2025 |
EPS Normalized Actual | $2.15 (Beat by $0.19) |
EPS GAAP Actual | $2.15 (Beat by $0.19) |
Revenue Actual | $5.186B |
Revenue Surprise | Beat by $5186M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.83352 |
EPS GAAP Estimate | $2.83352 |
Revenue Estimate | $5.79103338B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 12.85679 | 14.69 | 12.44357 | 13.56302 | 1 |
Dec 2026 | 11.90016 | 15.87 | 11.9 | 11.90032 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.98 | 1.98 | 5.186B | 3.23% | 5186M |
FQ3 2024 (Sep 2024) | 6.4 | 6.4 | 5.5166B | -2.02% | 5516.6M |
FQ2 2024 (Jun 2024) | 2.1 | 2.1 | 5.4234B | -3.74% | 5423.4M |
FQ1 2024 (Mar 2024) | 1.61 | 1.61 | 4.8727B | -4.73% | 4872.7M |
FQ4 2023 (Dec 2023) | 2.21 | 2.21 | 5.0185B | -8.37% | 5018.5M |
FQ3 2023 (Sep 2023) | 2.35 | 2.35 | 5.6283B | -10.43% | 5628.3M |
FQ2 2023 (Jun 2023) | 1.95 | 1.95 | 5.6261B | 100% | 5626.1M |
FQ1 2023 (Mar 2023) | 1.7 | 1.7 | 5.1031B | 100% | 5103.1M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
2.83352
Consensus Revenue Estimates
5.79103338B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.35977 | -- | 3.25806 | 3.42939 | 2 |
FQ2 2027 (Jun 2027) | 2.84224 | -- | 2.75619 | 2.90114 | 2 |
FQ1 2027 (Mar 2027) | 2.21592 | -- | 2.1498 | 2.26285 | 2 |
FQ4 2026 (Oct 2026) | 3.62901 | -- | 3.55116 | 3.74452 | 3 |
FQ3 2026 (Jul 2026) | 2.99455 | -- | 2.93031 | 3.08987 | 5 |
FQ2 2026 (Jun 2026) | 3.11765 | -- | 2.94372 | 3.19663 | 5 |
FQ1 2026 (Mar 2026) | 2.60601 | -- | 2.46062 | 2.67203 | 3 |
FQ4 2025 (Oct 2025) | 3.07537 | 35.62 | 3.0094 | 3.17326 | 4 |
FQ3 2025 (Jul 2025) | 2.81455 | -127.39 | 2.75417 | 2.90414 | 6 |
FQ2 2025 (Jun 2025) | 2.83352 | 25.89 | 2.67544 | 2.90531 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 6.75B | -- | 6.59B | 6.85B | 3 |
FQ2 2027 (Jun 2027) | 5.98B | -- | 5.84B | 6.07B | 3 |
FQ1 2027 (Mar 2027) | 5.24B | -- | 5.12B | 5.33B | 3 |
FQ4 2026 (Oct 2026) | 6.81B | -- | 6.69B | 6.97B | 4 |
FQ3 2026 (Jul 2026) | 6.04B | -- | 5.95B | 6.19B | 5 |
FQ2 2026 (Jun 2026) | 6.48B | -- | 6.2B | 6.61B | 5 |
FQ1 2026 (Mar 2026) | 5.78B | -- | 5.53B | 5.9B | 6 |
FQ4 2025 (Oct 2025) | 6.2B | 16.3 | 6.09B | 6.35B | 2 |
FQ3 2025 (Jul 2025) | 5.76B | 4.16 | 5.66B | 5.9B | 2 |
FQ2 2025 (Jun 2025) | 5.79B | 6.35 | 5.54B | 5.9B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.98 | 1.98 | 100% | |
FQ3 2024 (Sep 2024) | 6.4 | 6.4 | 100% | |
FQ2 2024 (Jun 2024) | 2.1 | 2.1 | 100% | |
FQ1 2024 (Mar 2024) | 1.61 | 1.61 | 100% | |
FQ4 2023 (Dec 2023) | 2.21 | 2.21 | 100% | |
FQ3 2023 (Sep 2023) | 2.35 | 2.35 | 100% | |
FQ2 2023 (Jun 2023) | 1.95 | 1.95 | 100% | |
FQ1 2023 (Mar 2023) | 1.7 | 1.7 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $5.19B | $5186M | 100% |
FQ3 2024 (Sep 2024) | $0B | $5.52B | $5516.6M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.42B | $5423.4M | 100% |
FQ1 2024 (Mar 2024) | $0B | $4.87B | $4872.7M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.02B | $5018.5M | 100% |
FQ3 2023 (Sep 2023) | $0B | $5.63B | $5628.3M | 100% |
FQ2 2023 (Jun 2023) | $0B | $5.63B | $5626.1M | 100% |
FQ1 2023 (Mar 2023) | $0B | $5.1B | $5103.1M | 100% |